The director of melanoma research within the Northwestern Skin Cancer Institute presented his validation study at a meeting of the American Academy of Dermatology.
Published in the Journal of Clinical Investigation, the lab of Kathleen Green, PhD, has discovered desmoglein 1’s role in promoting the skin’s differentiation program.